Johnson Midwest Financial’s Bristol-Myers Squibb BMY Stock Holding History

Johnson Midwest Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$10.3K	Buy	177 +1	+0.6%	+$61	0.02%	203
2023 Q2	$11.2K	Buy	176 +2	+1%	+$134	0.01%	198
2023 Q1	$12.1K	Buy	174 +1	+0.6%	+$71	0.02%	190
2022 Q4	$12K	Buy	173 +1	+0.6%	+$75	0.04%	182
2022 Q3	$12	Sell	172 -9	-5%	-$653	0.05%	176
2022 Q2	$13K	Buy	181 +12	+7%	+$914	0.02%	162
2022 Q1	$12K	Buy	169 +1	+0.6%	+$67	0.02%	156
2021 Q4	$10K	Buy	168 +1	+0.6%	+$59	0.01%	180
2021 Q3	$10K	Buy	167 +2	+1%	+$132	0.01%	182
2021 Q2	$11K	Buy	165 +1	+0.6%	+$65	0.01%	163
2021 Q1	$10K	Buy	164 +1	+0.6%	+$62	0.01%	163
2020 Q4	$10K	Buy	+163	New	+$10K	0.01%	166

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Johnson Midwest Financial's BMY Position: Q3 2023 in Review

Johnson Midwest Financial increased its Bristol-Myers Squibb (BMY) stake by 0.57% in Q3 2023, buying an estimated $61 and bringing the position to 177 shares worth $10.3K. The position accounts for 0.02% of the portfolio, ranked #203.

Johnson Midwest Financial first reported a position in BMY in Q4 2020 and has held it in 12 quarters since. The position peaked at $13K in Q2 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Johnson Midwest Financial held 177 shares of Bristol-Myers Squibb worth $10.3K as of Q3 2023.
Johnson Midwest Financial bought 1 Bristol-Myers Squibb share in Q3 2023, an estimated $61.
Bristol-Myers Squibb made up 0.02% of Johnson Midwest Financial's portfolio in Q3 2023, its #203 holding.
Johnson Midwest Financial first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 12 quarters since.
Johnson Midwest Financial's Bristol-Myers Squibb position peaked at $13K in Q2 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.